Meeting News

Anticoagulants confer comparable risks for adverse events in patients undergoing PCI

December 21, 2016
NEW ORLEANS — The use of warfarin or apixaban produced similar bleeding and stroke rates in patients undergoing percutaneous coronary…
Meeting News

‘Smoker’s paradox’ exists in patients undergoing PCI for STEMI, regardless of blood thinner therapy

December 1, 2016
Smoking independently predicted more favorable in-hospital mortality rates – consistent with the “smoker’s paradox” –…
Meeting News

Bivalirudin ‘lends some reassurance’ regarding bleeding risk in patients with end-stage renal disease

November 30, 2016
NEW ORLEANS — The use of bivalirudin in patients with end-stage renal disease undergoing PCI demonstrated a reduced rate of bleeding and…
Meeting News

Heparin plus short-term tirofiban demonstrates less bleeding than bivalirudin during PCI

November 28, 2016
NEW ORLEANS — The use of heparin plus short-term infusions of tirofiban during elective or urgent PCI demonstrated no significant differences…
Meeting NewsVideo

VIDEO: PIONEER AF-PCI results may not translate to clinical practice

November 23, 2016
NEW ORLEANS — Study results presented at the American Heart Association Scientific Sessions demonstrated an anticoagulation strategy involving…